148 related articles for article (PubMed ID: 7913713)
1. Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice.
Pouvelle B; Farley PJ; Long CA; Taraschi TF
J Clin Invest; 1994 Jul; 94(1):413-7. PubMed ID: 7913713
[TBL] [Abstract][Full Text] [Related]
2. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
3. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro.
Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS
Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.
Sinou V; Grellier P; Schrevel J
Antimicrob Agents Chemother; 1996 Feb; 40(2):358-61. PubMed ID: 8834880
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
Min-Oo G; Ayi K; Bongfen SE; Tam M; Radovanovic I; Gauthier S; Santiago H; Rothfuchs AG; Roffê E; Sher A; Mullick A; Fortin A; Stevenson MM; Kain KC; Gros P
Exp Parasitol; 2010 Aug; 125(4):315-24. PubMed ID: 20219464
[TBL] [Abstract][Full Text] [Related]
6. Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.
Lopes SC; Blanco YC; Justo GZ; Nogueira PA; Rodrigues FL; Goelnitz U; Wunderlich G; Facchini G; Brocchi M; Duran N; Costa FT
Antimicrob Agents Chemother; 2009 May; 53(5):2149-52. PubMed ID: 19273690
[TBL] [Abstract][Full Text] [Related]
7. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.
Li X; He Z; Chen L; Li Y; Li Q; Zhao S; Tao Z; Hu W; Qin L; Chen X
Parasitol Res; 2011 Dec; 109(6):1519-24. PubMed ID: 21537980
[TBL] [Abstract][Full Text] [Related]
8. Interruption of the blood-stage cycle of the malaria parasite, Plasmodium chabaudi, by protein tyrosine kinase inhibitors.
Gazarini ML; Garcia CR
Braz J Med Biol Res; 2003 Nov; 36(11):1465-9. PubMed ID: 14576900
[TBL] [Abstract][Full Text] [Related]
9. N1-acetyl-N2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites.
Budu A; Peres R; Bueno VB; Catalani LH; Garcia CR
J Pineal Res; 2007 Apr; 42(3):261-6. PubMed ID: 17349024
[TBL] [Abstract][Full Text] [Related]
10. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.
Shear HL; Grinberg L; Gilman J; Fabry ME; Stamatoyannopoulos G; Goldberg DE; Nagel RL
Blood; 1998 Oct; 92(7):2520-6. PubMed ID: 9746793
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
13. Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen.
Yadava A; Kumar S; Dvorak JA; Milon G; Miller LH
Proc Natl Acad Sci U S A; 1996 May; 93(10):4595-9. PubMed ID: 8643449
[TBL] [Abstract][Full Text] [Related]
14. Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.
He Z; Qin L; Chen L; Peng N; You J; Chen X
Antimicrob Agents Chemother; 2008 Jul; 52(7):2653-6. PubMed ID: 18443126
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical Aspects of the Plasmodium chabaudi-Infected Erythrocyte.
Hayakawa EH; Kobayashi S; Matsuoka H
Biomed Res Int; 2015; 2015():642729. PubMed ID: 26557685
[TBL] [Abstract][Full Text] [Related]
16. Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice.
Koka S; Bobbala D; Lang C; Boini KM; Huber SM; Lang F
Cell Physiol Biochem; 2009; 23(1-3):191-8. PubMed ID: 19255513
[TBL] [Abstract][Full Text] [Related]
17. A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami.
Gadsby N; Lawrence R; Carter R
Int J Parasitol; 2009 Feb; 39(3):347-54. PubMed ID: 18755194
[TBL] [Abstract][Full Text] [Related]
18. Host Porphobilinogen Deaminase Deficiency Confers Malaria Resistance in
Schnider CB; Yang H; Starrs L; Ehmann A; Rahimi F; Di Pierro E; Graziadei G; Matthews K; De Koning-Ward T; Bauer DC; Foote SJ; Burgio G; McMorran BJ
Front Cell Infect Microbiol; 2020; 10():464. PubMed ID: 33014890
[TBL] [Abstract][Full Text] [Related]
19. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
[TBL] [Abstract][Full Text] [Related]
20. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
Scorza T; Grubb K; Smooker P; Rainczuk A; Proll D; Spithill TW
Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
